UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 97

Sortiert nach

Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR

Nucleic acids research, 2005-01, Vol.33 (15), p.4813

2005

Volltextzugriff (PDF)

Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas

Blood, 2003-05, Vol.101 (9), p.3574-3580

2003

Volltextzugriff (PDF)

1st-line mFOLFOXIRI + panitumumab vs FOLFOXIRI treatment of RAS wt mCRC: A randomized phase II VOLFI trial of the AIO (KRK-0109)

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii150

2018

Volltextzugriff (PDF)

Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)

Journal of cancer research and clinical oncology, 2020-10, Vol.146 (10), p.2681-2691

2020

Volltextzugriff (PDF)

2049 AIO-KRK-0109: A randomized phase II trial of panitumumab plus FOLFOXIRI or FOLFOXIRI alone as 1st-line treatment in RAS-wild-type metastatic colorectal cancer (mCRC)

European journal of cancer (1990), 2015-09, Vol.51, p.S344-S345

2015

Volltextzugriff (PDF)

Inhibition of the synthesis of apolipoprotein B-containing lipoproteins

Handbook of experimental pharmacology, 2005 (170), p.483

Greeve, J

2005

Volltextzugriff (PDF)

Schilddrüsenstörungen in der Schwangerschaft

Gynäkologie (Heidelberg, Germany), 2003-11, Vol.36 (11), p.965-973

Greeve, J

2003

Volltextzugriff (PDF)

Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease

Journal of thoracic oncology, 2015-01, Vol.10 (1), p.156-163

2015

Volltextzugriff (PDF)

Immunoglobulin class-switch recombination occurs in mantle cell lymphomas

The Journal of pathology, 2006-06, Vol.209 (2), p.250-257

2006

Volltextzugriff (PDF)

Sitosterolaemia in Switzerland: molecular genetics links the US Amish-Mennonites to their European roots

Clinical genetics, 2005-08, Vol.68 (2), p.174-178

2005

Volltextzugriff (PDF)

Afatinib in Non‐Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors

The oncologist (Dayton, Ohio), 2015-10, Vol.20 (10), p.1167-1174

2015

Volltextzugriff (PDF)

mFOLFOXIRI + panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild-type metastatic colorectal cancer m(CRC): A randomized phase II VOLFI trial of the AIO (AIO-KRK0109)

Annals of oncology, 2017-09, Vol.28, p.v159-v159

2017

Volltextzugriff (PDF)

Sequence requirements for the editing of apolipoprotein B mRNA

The Journal of biological chemistry, 1991-09, Vol.266 (25), p.16301-16304

1991

Volltextzugriff (PDF)

Hepatitis B: modern concepts in pathogenesis – APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus

Current opinion in infectious diseases, 2008-06, Vol.21 (3), p.298-303

2008

Volltextzugriff (PDF)

Purification and Molecular Cloning of a Novel Essential Component of the Apolipoprotein B mRNA Editing Enzyme-Complex

The Journal of biological chemistry, 2000-06, Vol.275 (26), p.19848-19856

2000

Volltextzugriff (PDF)

Experience With Afatinib in Patients With Non‐Small Cell Lung Cancer Progressing After Clinical Benefit From Gefitinib and Erlotinib

The oncologist (Dayton, Ohio), 2014-10, Vol.19 (10), p.1100-1109

2014

Volltextzugriff (PDF)

Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits

Journal of lipid research, 1996-09, Vol.37 (9), p.2001-2017

1996

Volltextzugriff (PDF)

Regulation of the hepatic removal of chylomicron remnants and beta-very low density lipoproteins in the rat

Journal of lipid research, 1992-03, Vol.33 (3), p.419-429

1992

Volltextzugriff (PDF)

Site-specific creation of uridine from cytidine in apolipoprotein B mRNA editing

Nucleic acids research, 1991-03, Vol.19 (6), p.1197-1201

1991

Volltextzugriff (PDF)

Gastrointestinal hemorrhage in a 74-year-old man after abdominal aortic aneurysm surgery. 74-year-old married, retired patient

Praxis (Bern. 1994), 2006-03, Vol.95 (9), p.327

2006

Volltextzugriff (PDF)

The human asialoglycoprotein receptor is a possible binding site for low-density lipoproteins and chylomicron remnants

Biochemical journal, 1991-05, Vol.276 (1), p.79-87

1991

Volltextzugriff (PDF)

Interferon-α stimulation of liver cells enhances hepatitis delta virus RNA editing in early infection

Journal of hepatology, 2004-10, Vol.41 (4), p.667-672

2004

Volltextzugriff (PDF)

Induction of hepatic apolipoprotein B mRNA editing for reducing serum cholesterol levels: A breakthrough or a disaster

Hepatology (Baltimore, Md.), 1996-10, Vol.24 (4), p.964-966

1996

Volltextzugriff (PDF)

69-year-old patient with anemia, hypothyroidism and transferrin saturation

Praxis (Bern. 1994), 2004-07, Vol.93 (29-30), p.1202

2004

Volltextzugriff (PDF)

Reconstitution of apoB mRNA editing in liver by gene-transfer as a potential approach for the treatment of severe forms of polygenic hypercholesterolemia--an outline of the rationale

Zeitschrift für Gastroenterologie, 1996-06, Vol.34 Suppl 3, p.27

1996

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(96)
Buchkapitel
(1)

Sprache

Englisch
(92)
Japanisch
(16)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(55)
Life Sciences & Biomedicine
(53)
Humans
(49)
Animals
(33)
Biological And Medical Sciences
(26)
Male
(25)
Female
(20)
Aged
(17)
Middle Aged
(17)
Biochemistry & Molecular Biology
(16)
Medical Sciences
(16)
Rats
(16)
Adult
(12)
Base Sequence
(12)
Fundamental And Applied Biological Sciences. Psychology
(12)
Liver - Metabolism
(12)
Molecular Sequence Data
(12)
Apolipoproteins B - Genetics
(11)
Rna, Messenger - Metabolism
(11)
Apobec-1 Deaminase
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR

Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas

1st-line mFOLFOXIRI + panitumumab vs FOLFOXIRI treatment of RAS wt mCRC: A randomized phase II VOLFI trial of the AIO (KRK-0109)

Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)

2049 AIO-KRK-0109: A randomized phase II trial of panitumumab plus FOLFOXIRI or FOLFOXIRI alone as 1st-line treatment in RAS-wild-type metastatic colorectal cancer (mCRC)

Inhibition of the synthesis of apolipoprotein B-containing lipoproteins

Schilddrüsenstörungen in der Schwangerschaft

Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease

Immunoglobulin class-switch recombination occurs in mantle cell lymphomas

Sitosterolaemia in Switzerland: molecular genetics links the US Amish-Mennonites to their European roots

Afatinib in Non‐Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors

mFOLFOXIRI + panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild-type metastatic colorectal cancer m(CRC): A randomized phase II VOLFI trial of the AIO (AIO-KRK0109)

Sequence requirements for the editing of apolipoprotein B mRNA

Hepatitis B: modern concepts in pathogenesis – APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus

Purification and Molecular Cloning of a Novel Essential Component of the Apolipoprotein B mRNA Editing Enzyme-Complex

Experience With Afatinib in Patients With Non‐Small Cell Lung Cancer Progressing After Clinical Benefit From Gefitinib and Erlotinib

Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits

Regulation of the hepatic removal of chylomicron remnants and beta-very low density lipoproteins in the rat

Site-specific creation of uridine from cytidine in apolipoprotein B mRNA editing

Gastrointestinal hemorrhage in a 74-year-old man after abdominal aortic aneurysm surgery. 74-year-old married, retired patient

The human asialoglycoprotein receptor is a possible binding site for low-density lipoproteins and chylomicron remnants

Interferon-α stimulation of liver cells enhances hepatitis delta virus RNA editing in early infection

Induction of hepatic apolipoprotein B mRNA editing for reducing serum cholesterol levels: A breakthrough or a disaster

69-year-old patient with anemia, hypothyroidism and transferrin saturation

Reconstitution of apoB mRNA editing in liver by gene-transfer as a potential approach for the treatment of severe forms of polygenic hypercholesterolemia--an outline of the rationale

Suchergebnisse filtern